hVIVO plc (AIM:HVO)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 5.55
+0.10 (1.76%)
Oct 23, 2026, 4:37 PM BST
hVIVO Market Cap
hVIVO has a market cap or net worth of 38.13 million as of October 23, 2026. It is the 29,948th most valuable company in the world and the 670th biggest in the United Kingdom. Its market cap has decreased by 19.94% in one year.
Market Cap
38.13M
Enterprise Value
39.07M
Revenue
42.09M
Global Rank
Country Rank
#670 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since July 1, 2019, hVIVO's market cap has increased from 17.24M to 38.13M, an increase of 121.20%. That is a compound annual growth rate of 11.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 38.13M | -11.04% |
| Dec 31, 2025 | 42.86M | -69.27% |
| Dec 31, 2024 | 139.48M | -13.68% |
| Dec 29, 2023 | 161.59M | 140.84% |
| Dec 30, 2022 | 67.09M | -56.52% |
| Dec 31, 2021 | 154.31M | -10.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 195.65B |
| GSK plc | 74.85B |
| Haleon | 32.82B |
| Smith & Nephew | 9.11B |
| Creo Medical Group | 48.19M |
| Poolbeg Pharma | 47.71M |
| Abingdon Health | 39.16M |
| MedPal AI | 38.77M |